Addex to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Geneva, Switzerland, September 8, 2021 – Addex Therapeutics (SIX: ADXN), a clinical-stage pharmaceutical company pioneering allosteric…
Month: September 2021
Sanofi to acquire Kadmon to further strengthen growth of transplant business
Sanofi to acquire Kadmon to further strengthen growth of transplant business Adds Rezurock™ (belumosudil) an…
Bone Therapeutics reports half year 2021 results
REGULATED INFORMATION The interim financial report is prepared in accordance with article 13 of the…
Angion Hosting Research & Development Day on ANG-3070 for the Treatment of Lung and Kidney Fibrosis
UNIONDALE, N.Y., Sept. 08, 2021 (GLOBE NEWSWIRE) — Angion Biomedica Corp. (NASDAQ:ANGN), a late-stage biopharmaceutical…
Avicanna Announces Filing of Interim Financial Statements For Three Month Period Ended March 31, 2021
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES….
Australian biotech, EnGeneIC, develops world-first nanocellular anti-COVID-19 vaccine that defeats mutant viruses and stimulates a broad anti-viral response
Works against mutant strains including Delta No need for refrigeration during transport and storage No…
Genocea to Present at Upcoming Scientific and Investor Conferences
CAMBRIDGE, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (Nasdaq: GNCA), a biopharmaceutical…
PharmaTher Provides Business Highlights and Releases Annual Financials for Fiscal Year Ended May 31, 2021
TORONTO, Sept. 07, 2021 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB:…
Ocugen, Inc. to Present at Upcoming Citi and H.C. Wainwright Investment Conferences
MALVERN, Pa., Sept. 07, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused…
Adaptive Biotechnologies to Present at the Morgan Stanley Global Healthcare Conference
SEATTLE, Sept. 07, 2021 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT) a commercial stage…
Ascendis Pharma A/S Announces Upcoming Investor Presentations
COPENHAGEN, Denmark, Sept. 07, 2021 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical…
Ascendis Pharma A/S Submits Investigational New Drug Application to Initiate TransCon™ IL-2 β/γ Clinical Program
– TransCon IL-2 β/γ is an investigational long-acting prodrug designed to improve cancer immunotherapy through the…
Krystal Biotech to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
PITTSBURGH, Sept. 07, 2021 (GLOBE NEWSWIRE) — Krystal Biotech Inc., (“Krystal”) (NASDAQ: KRYS), the leader…
AzurRx BioPharma to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment Conference
BOCA RATON, Fla., Sept. 07, 2021 (GLOBE NEWSWIRE) — AzurRx BioPharma, Inc. (“AzurRx” or the…
MacroGenics Announces Final Overall Survival Results from SOPHIA Study of MARGENZA™ in Patients with HER2-Positive Metastatic Breast Cancer
Final overall survival (OS) analysis did not demonstrate a statistically significant advantage for MARGENZA over…
GBS Inc. to Present at Upcoming September Virtual Investor Conferences
H.C. Wainwright 23rd Global Investor Conference: September 13th– 15th Benzinga Healthcare Small Cap Conference: September…
Corvus Pharmaceuticals Announces Participation in Upcoming Investor Conferences
BURLINGAME, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage…
Revolution Medicines to Present at H.C. Wainwright 23rd Annual Global Investment Conference
REDWOOD CITY, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a…
Sana Biotechnology to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
SEATTLE, Sept. 07, 2021 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused…
Elemica Expands Order-to-Cash Process Automation Platform
The successful integration of OmPrompt technologies means organizations can now digitize the whole order-to-cash cycle…